Rights and permissions
About this article
Cite this article
CYP2C9-based warfarin therapy better value than standard care. Inpharma Wkly. 1459, 3 (2004). https://doi.org/10.2165/00128413-200414590-00004
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-200414590-00004